[ad_1]
Cook Medical today announced it signed a letter of intent with CooperCompanies to sell the entirety of Cook’s Reproductive Health business within the MedSurg division. CooperCompanies (NYSE:COO), a publicly held healthcare company, is focused on women’s health and fertility solutions, providing innovative products and services for every step in the ART journey. Under the proposed transaction, CooperCompanies will pay $875 million comprised of $675 million at closing and $200 million paid in four $50 million annual installments. The proposed transaction is subject to compliance with applicable local consultation obligations and regulatory approvals.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220207005939/en/
Cook Medical’s Reproductive Health product line. (Photo: Business Wire)
For more than 40 years, Cook has had a focus on Reproductive Health, successfully developing products for obstetrics and gynecology, In …
Full story available on Benzinga.com
[ad_2]
Source link
